期刊文献+

老年急性冠脉综合征患者脑钠肽水平对预后的评估分析 被引量:2

The assessment of the prognosis of elderly patients with acute coronary syndrome with brain natriuretic peptide levels
下载PDF
导出
摘要 目的总结老年急性冠脉综合征(65≥岁)患者脑钠肽(BNP)水平对远近期预后的评估价值。方法选择不稳定型心绞痛(UAP)患者50例、急性ST段抬高型心肌梗死(STEMI)患者21例,急性非ST段抬高心肌梗死(NSTEMI)患者29例,正常对照组20例。测定其入院时和出院时血浆BNP浓度,与正常对照组20例相比较,观察并随访住院期间和出院后24个月内不良心脏事件的发生率、病死率。结果不稳定型心绞痛(UAP)、急性ST段抬高型心肌梗死(STEMI)、急性非ST段抬高型心肌梗死(NSTEMI)的BNP分别为(780.51±89.52)ng/L,(8588.04±369.50)ng/L和(3430.86±270.25)ng/L,冠脉病变越重,BNP越高,说明BNP与心肌缺血之间是关联的。BNP≥550 ng/L的患者住院期间与出院后24个月内不良心脏事件、病死率均高于BNP<550 ng/L的患者。结论BNP可以准确地评估ACS患者的危险程度和近远期预后。 Objective:To summarize the assessing value of brain natriuretfc peptide (BNP) levels in the fax-term prognosis of acute coronary syndrome ( ≥ 65years) patients. Methods: We selected 50 patients with unstable angina pectoris (UAP) ,21 patients with acute ST -segment elevation myocardial infarction (STEMI), 29 patients with acute non-ST-segment elevation myocardial infarction (NSTEMI) in, and normal control group of 20 patients. Measured plasma BNP levels at admission and discharge, the 20 patients in normal control group were used as eomparlson to observe and the incidence and the mortality of adverse cardiac events within 24 months during hospitalization and after discharge. Results: unstable angina pcctoris (UAP), acute ST-segment elevation myocardial infarction (STEMI), acute non-ST-segment elevation myocordial infarction (NSTEMI) BNP (780.51± 89.52) ng/L, (8588.04 ±369.50) ng/L, (3430.86 ± 270.25 ) ng/L, coronary lesions heavier, BNP higher the BNP and myocardial isehemia is associated. BNP ≥ 550 ng / L in patients during hospitalization and adverse cardiac events within 24 months after discharge mortality than BNP 〈 550ng / L in patients. Conclusion : BNP can accurately assess the degree of risk and near-term prognosis of patients with ACS.
出处 《泰山医学院学报》 CAS 2012年第9期685-686,共2页 Journal of Taishan Medical College
关键词 脑钠肽 急性冠脉综合征 预后 brain natriuretic peptide acute coronary syndrome prognosis
  • 相关文献

参考文献7

  • 1Toth M, Vuofinen KH, Vuolteenaho O, et al. Hypoxia st imulates release of ANP an d BNP from perfused rat vent rieular myocardi- um [J]. Am J Physiol, 1994, 266:H1572.
  • 2Blankberg S, MeQueen M J, Smieja M, et al. Comparative impact of multiple biomarkers and N-terminal probmin natfiuretic peptide in the context of conventional risk factors for the prediction of recur- rent cardiovascular events in the heart outcomes prevention evalua- tion (HOPE) study[ J ]. Circulation, 2006,114:201-208.
  • 3顾祎,段俊丽,王一尘.脑钠肽和氨基端脑钠肽前体的临床应用进展[J].国外医学(老年医学分册),2008,29(4):145-149. 被引量:6
  • 4Jernberg T, Stridsberg M, Verge P, et al. N-terminai probrain natri- uretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elebation[ J]. J Am Coll Cardi- o1,2002 ;40:437-445.
  • 5Heesehen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natriurctic peptide levels for dynamic risk stratification of patients with acute coronary syndromes [ J ]. Circulation, 2004,110 : 3206- 3212.
  • 6Euler R F, MANENT 1. Prognostic value of serum b iomarkers ion with TIMI risk score for acute coronary syndromes[ J]. Clin Cardi- o1,2006 ,29 :354.
  • 7傅燕琳.NT-pro-BNP在治疗ACS中的应用和意义[J].中国实用医药,2010,5(4):55-57. 被引量:9

二级参考文献35

  • 1蒋作锋,韦建瑞,余慧文,郭顺华,张锐,张文超,陈辉,黄丽萍,郭衡山.原发性高血压患者N端脑钠肽前体测定及其意义[J].岭南心血管病杂志,2005,11(6):383-385. 被引量:4
  • 2潘柏申,蔡乃绳,李清,范维琥,李勇,郭玮,周琰,陶青.表面健康人群氨基末端B型利钠肽参考范围调查[J].中华检验医学杂志,2006,29(1):23-26. 被引量:65
  • 3史晓敏,徐国宾,夏铁安.肾功能与N末端B型钠尿肽原的关系及其在慢性心力衰竭诊断中的应用[J].中华检验医学杂志,2006,29(12):1089-1092. 被引量:13
  • 4Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002; 347 (3): 161-167
  • 5Mair J, Hammerer - lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med, 2001; 39 (7): 571-588
  • 6de Lemos JA, MeGuire DK, Drazner MH. B type natriuretic peptlde in cardiovascular disease . Lancet, 2003; 362: 316 - 322
  • 7Maeda K, Tsutamoto T, Wada A et al. Plasma brain natriuretic peptide as a bioehemical marker of high left ventricu-lar end - diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1988; 135 (5 Pt1 ) : 825 - 832
  • 8Weber M, Hamm C. Role of B - type natriuretic peptide (BNP) and NT -proBNP in clinical routine. Heart, 2006; 92 : 843 - 849
  • 9Redfield MM, Rodeheffer R J, Jacobsen SJ et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coil Cardiol, 2002 ; 40 : 976 - 982
  • 10Luchner A, Hengstenherg C, Lowel H et al. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natrluretic peptide (BNP) and N - terminal pro - BNP. Hypertension, 2005; 46: 118 - 123

共引文献13

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部